22346-07-2

Basic information

• Product Name: alpha-(2-methylpropylidene)pyridine-2-acetonitrile
• Synonyms: alpha-(2-methylpropylidene)pyridine-2-acetonitrile;α-(2-Methylpropylidene)-2-pyridineacetonitrile;Einecs 244-923-9
• CAS NO: 22346-07-2
• Molecular Formula: C₁₁H₁₂N₂
• Molecular Weight: 172.22638
• EINECS: 244-923-9
• Mol File: 22346-07-2.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 293.4°Cat760mmHg
• Flash Point: 108.1°C
• Appearance: /
• Density: 1.011g/cm³
• CAS DataBase Reference: alpha-(2-methylpropylidene)pyridine-2-acetonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: alpha-(2-methylpropylidene)pyridine-2-acetonitrile(22346-07-2)
• EPA Substance Registry System: alpha-(2-methylpropylidene)pyridine-2-acetonitrile(22346-07-2)

Safety Data

• Hazardous Substances Data: 22346-07-2(Hazardous Substances Data)

Upstream product

• 110-89-4 piperidine 
• 2739-97-1 pyridine-2-acetonitrile 
• 78-84-2 isobutyraldehyde 
• 109-04-6 2-bromo-pyridine 
• 7605-28-9 2-(phenylsulfonyl)acetonitrile 

Downstream Products

• 78833-04-2 4-methyl-2-(2-pyridyl)pentanenitrile 
• 78833-05-3 2-<2-(diisopropylamino)ethyl>-4-methyl-2-(2-pyridyl)pentanenitrile 
• 78833-03-1 Pentisomide 
• 83918-19-8 2-[2-(Cyclohexyl-isopropyl-amino)-ethyl]-4-methyl-2-pyridin-2-yl-pentanenitrile 
• 78833-21-3 2-[2-(Cyclohexyl-isopropyl-amino)-ethyl]-4-methyl-2-pyridin-2-yl-pentanoic acid amide 
• 83918-22-3 2-(2-Dicyclohexylamino-ethyl)-4-methyl-2-pyridin-2-yl-pentanenitrile 
• 78833-25-7 2-(2-Dicyclohexylamino-ethyl)-4-methyl-2-pyridin-2-yl-pentanoic acid amide 

Relevant articles and documents

Palladium-catalyzed condensation of aryl halides with phenylsulfonylacetonitrile and diethyl cyanomethylphosphonate

-

Myocardium-protecting pyridine derivatives having an anti-arrhythmic activity and an activity as blood-platelets antiaggregants

The present invention relates to new pyridine derivatives of formula: STR1 wherein R1 is an alkyl or an alicyclic group, R2 and R3 are alkyls or alicyclic groups or form an heterocycle with the atom of nitrogen to which they are bonded; the invention also relates to a process for the preparation of said derivatives and the medicines containing at least one of the said derivatives.